PhD defence by Ida Kappel Buhl
Clinical utility of in vitro based drug-specific multigene biomarkers - Prediction of medical treatment outcomes in lung and breast cancer patients
(Chairperson) Associate Professor Claus Storgaard Sørensen, University of Copenhagen
Dr. Morten Mau-Sørensen, Rigshospitalet
Associate Professor Beverly Teicher, National Cancer Institute, US
Professor José Moreira, University of Copenhagen
Professor emeritus Steen Knudsen, Oncology Venture
Professor emeritus Nils Brünner, University of Copenhagen
PhD Anker Hansen, Oncology Venture
Drug Design and Pharmacology
Clinical Cancer Research
Place of experimental work
The experimental work took place at the Department of Drug Design and Pharmacology, University of Copenhagen, and at Oncology Venture.
Place of defence
The PhD defense can be accessed using the following link: https://ucph-ku.zoom.us/j/63289274748?pwd=SFFwY1U1Vkd5Wk1oaFlqUWg2Vk01QT09
Meeting-ID:632 8927 4748
To attend the PhD defence, please follow the link and hereafter the instructions to download the required Zoom-client. If the Zoom-client is incompatible with your pc, smartphone etc. you can attend via an Internet browser. Log-in in due time before to allow time to install the Zoom-client.
As the defence is held as a digital defence, we kindly ask guests who do not have an active role in the defence to mute your microphones and leave your cameras turned off during the defence.
The defense will follow the normal guidelines for a PhD defense, meaning; the Chair will initiate the defense, followed by Ida Kappel Buhl's presentation (app. 45 min) and thereafter the assessment committee will ask questions. The general audience is subsequently allowed to ask questions. For general audience to ask questions, we encourage the use of the chat function in order to keep track of questions.